Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Kozarich John W sold 467 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 2, 2026
On Apr 1, 2026, Kozarich John W (Director) sold 467 Ligand Pharmaceuticals Incorporated shares at an average US$202.22 for US$94,439 under a trading plan, leaving 42,253 shares. Filed Apr 2, 2026 (Form 4).
- Sold
- 467 shares
- Price
- US$202.22 average (US$199.97 to US$204.26)
- Value
- US$94,439
- Holding after
- 42,253 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Sale | 146 | US$199.97 | 42,574 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 40 | US$201.24 | 42,534 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 79 | US$202.42 | 42,455 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 43 | US$202.91 | 42,412 | Direct |
| Apr 1, 2026 | Common Stock | Sale | 159 | US$204.26 | 42,253 | Direct |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Kozarich John W
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Kozarich John W · Jun 9, 2026
- Form 4 · Kozarich John W · May 14, 2026
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Espinoza Octavio · Aug 14, 2026